SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001437749-16-043465
Filing Date
2016-12-16
Accepted
2016-12-16 16:19:54
Documents
4
Effectiveness Date
2016-12-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 bota20161209_s8.htm S-8 100103
2 EXHIBIT 5.1 ex5-1.htm EX-5.1 12957
3 EXHIBIT 23.1 ex23-1.htm EX-23.1 2962
4 EXHIBIT 23.2 ex23-2.htm EX-23.2 2860
  Complete submission text file 0001437749-16-043465.txt   120209
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Aviragen Therapeutics, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-8 | Act: 33 | File No.: 333-215141 | Film No.: 162056535
SIC: 2836 Biological Products, (No Diagnostic Substances)